Calyseed
Overview
Calyseed is a seed fund specializing in the healthcare sector, focusing on early-stage biotech companies in France. Established in 2023, Calyseed aims to support innovative startups in the life sciences by providing both financial and operational assistance. The fund primarily targets investments in the Auvergne-Rhône-Alpes region, leveraging its local presence to engage closely with entrepreneurs and foster the growth of promising healthcare ventures. Calyseed's investment strategy emphasizes active involvement in the development of its portfolio companies, offering strategic guidance and access to a network of experts to enhance their success. By focusing on the critical early stages of startup development, Calyseed seeks to increase the chances of success for deeptech startups in the healthcare sector.
Investment Focus
- Innovative healthcare solutions
- Strong management teams
- Scalable business models
Portfolio Companies
Reach Calyseed directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Calyseed
What sectors does Calyseed invest in?
Calyseed invests in Healthcare and Biotechnology, and is based in Auvergne-Rhône-Alpes, France. Calyseed is listed as a venture capital in the ConnectSafely investor database.
What stage does Calyseed invest at?
Calyseed backs companies at Seed and Early Stage.
Which regions does Calyseed invest in?
Calyseed invests across France.
What companies has Calyseed invested in?
Calyseed's portfolio includes MSInsight and MB Therapeutics.
Last updated · Source: ConnectSafely investor database
